Prevention of chemotherapy-induced alopecia using an effective scalp cooling system
Tài liệu tham khảo
Valero, 1998, A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer, J. Clin. Oncol., 16, 3362, 10.1200/JCO.1998.16.10.3362
Wood, 1994, Dose and dose intensity of adjuvant chemotherapy for stage II, node positive breast carcinoma, N. Engl. J. Med., 330, 1253, 10.1056/NEJM199405053301801
Giaccone, 1998, Randomised study of paclitaxel–cisplatin versus cisplatin–teniposide in patients with advanced non-small-cell lung cancer, J. Clin. Oncol., 16, 2133, 10.1200/JCO.1998.16.6.2133
Xiao, 1997, Long-term follow-up of patients with good-risk germ cell tumours treated with etoposide and cisplatin, J. Clin. Oncol., 15, 2553, 10.1200/JCO.1997.15.7.2553
Longo, 1997, Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease, J. Clin. Oncol., 15, 3338, 10.1200/JCO.1997.15.11.3338
Bonfante, 1992, ABVD in the treatment of Hodgkin's disease, Semin. Oncol., 19, 38
Carter, 1975, Adriamycin, J. Natl. Cancer Inst., 55, 1265, 10.1093/jnci/55.6.1265
Blum, 1974, Adriamycin, Ann. Intern. Med., 80, 249, 10.7326/0003-4819-80-2-249
Chevalier, 1995, Docetaxel is a major cytotoxic drug for the treatment of advanced breast cancer a phase II trial of the clinical screening cooperative group of the European Organisation for Research and Treatment of Cancer, J. Clin. Oncol., 13, 314, 10.1200/JCO.1995.13.2.314
Fountzilas, 1997, A randomised study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study, Ann. Oncol., 8, 1213, 10.1023/A:1008270307264
Slevin, 1989, A randomised trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer, J. Clin. Oncol., 7, 1333, 10.1200/JCO.1989.7.9.1333
Cline, 1984, Prevention of chemotherapy-induced alopecia, Cancer Nurs., 7, 221, 10.1097/00002820-198406000-00004
Ron, 1997, Scalp cooling in the prevention of alopecia in patients receiving depilating chemotherapy, Support Care Cancer, 5, 136, 10.1007/BF01262571
Srendi, 1995, Bone marrow sparing and prevention of alopecia by AS101 in non-small-cell lung cancer patients treated with carboplatin and etoposide, J. Clin. Oncol., 13, 2342, 10.1200/JCO.1995.13.9.2342
Hussein, 1993, Chemotherapy-induced alopecia, South Med. J., 86, 489, 10.1097/00007611-199305000-00001
Lemenager, 1997, Effectiveness of cold cap in the prevention of docetaxel-induced alopecia, Eur. J. Cancer, 33, 297, 10.1016/S0959-8049(96)00374-7
Gregory, 1982, Prevention of doxorubicin-induced alopecia by scalp hypothermia, Br. Med. J., 284, 1674, 10.1136/bmj.284.6330.1674
Guy, 1982, Scalp cooling by thermocirculator, Lancet, 246, 937, 10.1016/S0140-6736(82)91936-5
Tollenaar, 1994, Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer, Eur. J. Cancer, 30A, 1448, 10.1016/0959-8049(94)00280-I
Satterwhite, 1984, The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss, Cancer, 54, 34, 10.1002/1097-0142(19840701)54:1<34::AID-CNCR2820540109>3.0.CO;2-W
Lemenager, 1995, Docetaxel-induced alopecia can be prevented, Lancet, 346, 371, 10.1016/S0140-6736(95)92250-4
Fiebig HH, Beizer J, Klopfer P, et al. Scalp hypothermia for 2 hours prevents alopecia after adriamycin based chemotherapy. Proc ASCO 1997, 53.
Dean, 1979, Prevention of doxorubicin-induced hair loss with scalp hypothermia, N. Engl. J. Med., 301, 1427, 10.1056/NEJM197912273012605
Kiebert, 1990, Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer, Eur. J. Cancer, 26A, 1038, 10.1016/0277-5379(90)90046-V
Hillen, 1990, Scalp cooling by cold air for the prevention of chemotherapy-induced alopecia, Neth. J. Med., 37, 231
Bulow, 1985, Frontal subcutaneous blood flow, and epi- and subcutaneous temperatures during scalp cooling in normal man, Scand. J. Clin. Lab. Invest., 43, 505, 10.3109/00365518509155250
DeVita VT, Hellman S, Rosenberg SA, eds. Pharmacology of Cancer Chemotherapy. Philadelphia, Lippincott-Raven, 1997, 375–512.
Middleton, 1985, Failure of scalp hypothermia to prevent hair loss cyclophosphamide is added to doxorubicin and vincristine, Cancer Treat. Rep., 69, 373
Catimel, 1997, Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic breast cancer, Semin. Oncol., 24, 8
Gianni, 1995, Paclitaxel by 3-hour infusion in combination with bolus doxorubicin in women with untreated metastatic breast cancer, J. Clin. Oncol., 13, 2688, 10.1200/JCO.1995.13.11.2688
Dombernowky, 1996, Paclitaxel and doxorubicin, a highly active combination in the treatment of metastatic breast cancer, Semin. Oncol., 23, 13
Sledge, 1994, Paclitaxel (Taxol)/doxorubicin combinations in advanced breast cancer, Semin. Oncol., 21, 15
Holmes, 1995, Update, Semin. Oncol., 22, 9